Manufacturing Compliance Updates In Brief

EU GMP noncompliance notice sent to Chongqing Succeway Pharmaceutical Co Ltd. for poor data integrity; FDA hits several firms in China and Mexico with drug GMP import alerts; Canadian maker of skin products warned for not testing active ingredients; FDA warns of death and adverse event stemming from intravenous infusions of curcumin compounded with polyethylene glycol (PEG) 40 castor oil.

Ban Pills

More from Manufacturing

More from Compliance